Early detection of liver cancer: Diagnosis and management |
| |
Authors: | Michael L Volk Jorge A Marrero |
| |
Institution: | (1) Division of Gastroenterology and Hepatology, University of Michigan Health System, 3912 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA |
| |
Abstract: | Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer deaths worldwide, and the incidence is rising. Despite
a wide array of treatment options, fewer than half of candidates for potentially curative treatments receive them. The diagnosis
and management of HCC require a multidisciplinary approach involving various clinical specialties. The foundation of diagnosis
is high-quality imaging, with MRI being the test of choice. Some patients also require guided biopsy when MRI is equivocal.
Treatment options depend upon the tumor stage and the degree of underlying synthetic dysfunction. Potentially curative treatments
include surgical resection and transplantation. Other treatments that prolong survival include percutaneous ablation and transarterial
chemoembolization. A new oral agent, sorafenib, was recently shown to prolong survival in patients with advanced HCC. By increasing
surveillance and treatment of HCC, outcomes for these patients may be improved. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|